Document is current
Any future updates will be listed below
-
Authors
Peluso, M. J. https://orcid.org/0000-0003-0585-6230
Sandel, D. A. https://orcid.org/0000-0002-4095-2036
Deitchman, A. N. https://orcid.org/0000-0002-4722-463X
Kim, S. J.
Dalhuisen, T. https://orcid.org/0000-0001-9132-0496
Tummala, H. P. https://orcid.org/0009-0005-9493-3497
Tibúrcio, R.
Zemelko, L.
Borgo, G. M.
Singh, S. S.
Schwartz, K.
Deswal, M.
Williams, M. C.
Hoh, R.
Shimoda, M. https://orcid.org/0000-0002-6627-4624
Narpala, S.
Serebryannyy, L.
Khalili, M. https://orcid.org/0000-0001-9178-9139
Vendrame, E. https://orcid.org/0000-0002-5595-1773
SenGupta, D.
Whitmore, L. S. https://orcid.org/0000-0002-8721-8701
Tisoncik-Go, J. https://orcid.org/0000-0003-1381-265X
Gale, M. Jr https://orcid.org/0000-0002-6332-7436
Koup, R. A.
Mullins, J. I. https://orcid.org/0000-0002-4461-8158
Felber, B. K. https://orcid.org/0000-0001-8925-8128
Pavlakis, G. N.
Reeves, J. D.
Petropoulos, C. J. https://orcid.org/0000-0001-5496-8090
Glidden, D. V.
Spitzer, M. H. https://orcid.org/0000-0002-5291-3819
Gama, L.
Caskey, M. https://orcid.org/0000-0003-1727-8693
Nussenzweig, M. C. https://orcid.org/0000-0003-0592-8564
Chew, K. W. https://orcid.org/0000-0003-4865-4348
Henrich, T. J. https://orcid.org/0000-0002-6684-0622
Yukl, S. A.
Cohn, L. B.
Deeks, S. G. https://orcid.org/0000-0001-6371-747X
Rutishauser, R. L.
- License Information
-
More Information
Article History
Received: 2 March 2025
Accepted: 17 November 2025
First Online: 1 December 2025
Competing interests
: M.J.P. serves on a DSMB for American Gene Technologies. S.G.D. reports consulting fees from AbbVie, GSK, Hookipa, American Gene Technologies and Immunocore; owns Tendel stock; and receives research support from Gilead. M.H.S. is founder and shareholder of Pro Biosciences and Teiko.bio; has been a paid consultant for Five Prime, Ono, January, Earli, Astellas and Indaptus Therapeutics; and reports research funding from Roche/Genentech, Pfizer, Valitor and Bristol Myers Squibb. M.C. served on a Gilead scientific advisory board. M.C.N. has a patent to the bNAbs 10-1074 and 3BNC117 issued (Gilead); is on the scientific advisory board of Celldex and reports personal fees from Gilead and Frontier Biosciences. B.K.F., G.N.P. and J.I.M. are listed as inventors on US-Government-owned patents related to the CE DNA vaccine. M.K. has received funding to her institution from Gilead Sciences and Intercept Pharmaceuticals and serves as a scientific consultant for Gilead Sciences, GSK pharmaceuticals and Resolution Therapeutics. J.D.R. and C.J.P. are employees of Labcorp-Monogram Biosciences and shareholders of Labcorp. D.S. and E.V. are employees of and hold stock in Gilead Sciences.
